Bayer Recalls Afrin Nasal Spray Due to Child Poisoning Risk

  • Risk of serious injury or illness from child poisoning.
  • Company: Bayer HealthCare LLC
  • Medicine
  • CPSC
  • April 30, 2026

Product details

  • Travel Size Afrin® Original Nasal Spray 6 mL Bottles

Company announcement

Bayer is recalling travel-size Afrin Original Nasal Spray 6 mL bottles due to the risk of serious injury or illness from child poisoning.

The packaging violates the mandatory standard for child-resistant packaging.

The product was sold at retailers such as convenience stores and travel hubs including airports.

No injuries have been reported.

The recall date is April 30, 2026.

Risk:

The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging as required by the Poison Prevention Packaging Act. The 6 mL nasal spray’s packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning if the contents are swallowed by young children.

Impacted states: Nationwide

Products:

- Afrin® Original Nasal Spray 6 mL Bottles

Contact

For more information, call 800 317-2165.

View the original CPSC notice

Browse all recalls